No Matches Found
No Matches Found
No Matches Found
CARE Ratings Ltd
CARE Ratings Gains 5.85%: 3 Key Factors Driving the Week’s Momentum
CARE Ratings Ltd delivered a robust weekly performance, rising 5.85% from ₹1,623.55 on 12 June to ₹1,718.55 on 19 June 2026, comfortably outperforming the Sensex’s 2.35% gain over the same period. The week was marked by a significant upgrade in the company’s investment rating, a shift in technical momentum signalling bullish trends, and mixed but cautiously optimistic market signals. These developments collectively shaped investor sentiment and price action throughout the week.
CARE Ratings Ltd Technical Momentum Shifts Amid Mixed Market Signals
CARE Ratings Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish stance as of mid-June 2026. Despite a slight dip in daily price, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes, reflecting cautious optimism amid broader market volatility.
CARE Ratings Ltd Upgraded to Buy on Strong Financials and Bullish Technicals
CARE Ratings Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, and overall quality metrics. The small-cap capital markets firm’s mojo score has risen to 71.0, signalling renewed investor confidence amid robust quarterly results and bullish technical signals.
CARE Ratings Ltd Technical Momentum Shifts Signal Bullish Outlook
CARE Ratings Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by a combination of key technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signalling a potential uptrend for the capital markets company amid a mixed performance backdrop.
CARE Ratings Ltd Dips 0.84%: Mixed Signals Shape Weekly Performance
CARE Ratings Ltd closed the week marginally lower by 0.84%, ending at Rs.1,608.20 compared to Rs.1,621.85 the previous Friday. This slight underperformance was in line with the broader Sensex, which fell 0.78% over the same period, closing at 35,141.95. The week was marked by a downgrade in the company’s rating to Hold by MarketsMOJO amid mixed technical and valuation signals, alongside a subtle shift in technical momentum that tempered investor enthusiasm.
CARE Ratings Ltd is Rated Hold by MarketsMOJO
CARE Ratings Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
CARE Ratings Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals
CARE Ratings Ltd, a prominent player in the capital markets sector, has seen its investment rating downgraded from Buy to Hold as of 1 June 2026. This adjustment reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate solid financial performance and operational strength, evolving market dynamics and valuation metrics have prompted a more cautious stance among analysts.
CARE Ratings Ltd Technical Momentum Shifts Amid Mixed Market Signals
CARE Ratings Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of early June 2026. Despite a modest decline in share price, the stock’s technical indicators present a complex picture, reflecting both resilience and caution within the capital markets sector.
CARE Ratings Ltd is Rated Buy by MarketsMOJO
CARE Ratings Ltd is rated Buy by MarketsMOJO. This rating was last updated on 20 May 2026, reflecting a shift from the previous Hold status. However, the analysis and financial metrics discussed here represent the stock's current position as of 01 June 2026, providing investors with the latest insights into the company’s performance and outlook.
CARE Ratings Ltd Falls 4.07%: Key Technical Shifts and Upgrade Drive Volatility
CARE Ratings Ltd experienced a volatile week ending 22 May 2026, with its stock price declining 4.07% to close at Rs.1,727.95, underperforming the Sensex which gained 0.50% over the same period. Despite a strong technical signal early in the week, the stock faced selling pressure midweek before a modest recovery on the final trading day. Key developments including a Golden Cross formation, technical momentum shifts, and a rating upgrade shaped the stock’s trajectory amid mixed market sentiment.
CARE Ratings Ltd Upgraded to Buy on Strong Financials and Bullish Technicals
CARE Ratings Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality assessments. This upgrade, effective from 20 May 2026, is underpinned by robust quarterly results, bullish technical signals, and consistent long-term returns that outpace broader market benchmarks.
CARE Ratings Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Market Volatility
CARE Ratings Ltd, a small-cap player in the Capital Markets sector, has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a modest day decline of 2.04%, the stock’s underlying technical indicators and price action suggest a strengthening outlook, supported by robust moving averages and mixed but improving momentum signals.
Golden Cross Forms in CARE Ratings Ltd — On a Day the Stock Fell 4.07%. What the Mixed Signals Mean
The 50-day moving average has crossed above the 200-day moving average for CARE Ratings Ltd, signalling a golden cross on 18 Jun 2026. Yet, the stock declined 4.07% on the same day, while monthly technical indicators remain mildly bearish. This juxtaposition of signals calls for a detailed examination of the broader technical and fundamental context.
CARE Ratings Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook
CARE Ratings Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism for investors amid a small-cap capital markets environment.
CARE Ratings Ltd Gains 8.94%: 5 Key Factors Driving the Rally
CARE Ratings Ltd delivered a robust weekly performance, surging 8.94% from Rs.1,653.60 to Rs.1,801.35 between 11 and 15 May 2026, significantly outperforming the Sensex which declined 2.63% over the same period. The stock’s rally was marked by a strong midweek surge, technical momentum shifts, and an upgrade in analyst ratings, reflecting a blend of positive earnings, market sentiment, and technical signals.
Are CARE Ratings Ltd latest results good or bad?
CARE Ratings Ltd's latest results show a net profit of ₹52.83 crores, up 23.98% year-on-year, but with significant earnings volatility and a slowdown in growth compared to previous years, indicating a cautious outlook for investors.
CARE Ratings Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financials
CARE Ratings Ltd has seen its investment rating upgraded from Sell to Hold as of 14 May 2026, reflecting a notable improvement in technical indicators alongside steady financial performance. The company’s Mojo Score rose to 54.0, signalling a more balanced outlook amid a small-cap market capitalisation and a recent 8.1% intraday price surge. This upgrade is underpinned by four key parameters: Quality, Valuation, Financial Trend, and Technicals, each contributing to a more favourable assessment by analysts.
CARE Ratings Ltd Sees Technical Momentum Shift Amid Strong Price Rally
CARE Ratings Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, supported by mixed signals from key indicators such as MACD, RSI, and moving averages. This transition comes amid a strong price rally that outpaces the broader Sensex, signalling renewed investor interest in this small-cap capital markets player.
CARE Ratings Q4 FY26: Strong Profit Surge Masks Underlying Volatility Concerns
CARE Ratings Ltd., India's leading credit rating agency, reported a robust 47.16% quarter-on-quarter surge in consolidated net profit to ₹52.83 crores for Q4 FY26, marking a strong finish to the fiscal year. The ₹5,154 crore market capitalisation company posted a year-on-year profit growth of 23.98%, driven by improved operating leverage and better revenue realisation. Following the results announcement, the stock surged 8.10% to ₹1,736.75 on May 14, 2026, significantly outperforming the broader market.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
